The new material is capable of absorbing pharmaceutical drugs and allows the formation of blood vessels within the material’s pores, which increases the chances for a successful integration of the implant.
The experimental model created by IK4-CIDETEC is at the preclinical trial stage of testing.
More Articles on Ophthalmology:
Dr. David Ewing-Chow to Open Solo Practice
California Laws Prohibiting ‘One-Stop’ Optician Stores Remain Intact
American Academy of Ophthalmology Joins Choosing Wisely Campaign
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
